MED57 - Pharmaceutical GPO

The Commonwealth of Massachusetts is seeking to procure Pharmaceutical Group Purchasing Organization (GPO) services through the MED57 statewide contract opportunity. The contract will serve as the primary vehicle for Executive Agencies and other Eligible Entities to acquire pharmaceutical products and related services. The selected GPO vendor will be responsible for establishing and maintaining contracts with pharmaceutical manufacturers and suppliers to set acquisition pricing for drugs sold to the Commonwealth. Key requirements include demonstrating experience in pharmaceutical contracting and distribution, maintaining relationships with the three largest national drug wholesalers, and achieving a minimum of $2 billion in GPO sales. The contract term is for an initial 3-year period with two 1-year renewal options, for a total potential duration of 10 years. Pricing and the bidder's Supplier Diversity Program (SDP) plan will be the most heavily weighted evaluation criteria, with the SDP plan carrying a minimum 25% weight.

The Commonwealth makes no guarantee of purchase volumes and reserves the right to establish its own acquisition pricing or use pricing from other sources if deemed in its best interest. The contract is open to all qualified GPO vendors, with no set-asides or restrictions mentioned. The current incumbent vendor is Managed Health Care Associates Inc., but details on the pricing structure or existing contract values are not provided. Interested bidders must submit a Bidder Response Form, Prompt Pay Discount Form, and SDP Plan as part of their proposal, with the response due on May 11, 2023.